Somatropin Treatment to Final Height in Turner Syndrome
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
A randomized, controlled trial in girls with Turner syndrome at least 7 years old and younger
than 13 at study entry, to determine the efficacy and safety of Humatrope (somatropin)
treatment in promoting linear growth to final height.